A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This is a randomized Phase 1 study to evaluate the effects of Veliparib on cardiac
repolarization in patients with solid tumors who's cancer has recurred or is no longer
responding to current treatment.